Glen Eagle Advisors’s Biomea Fusion BMEA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$368 Hold
250
﹤0.01% 1045
2026
Q1
$383 Hold
250
﹤0.01% 980
2025
Q4
$310 Hold
250
﹤0.01% 1019
2025
Q3
$505 Hold
250
﹤0.01% 1052
2025
Q2
$450 Hold
250
﹤0.01% 988
2025
Q1
$533 Hold
250
﹤0.01% 993
2024
Q4
$970 Hold
250
﹤0.01% 966
2024
Q3
$2.52K Hold
250
﹤0.01% 869
2024
Q2
$1.13K Hold
250
﹤0.01% 979
2024
Q1
$3.74K Hold
250
﹤0.01% 811
2023
Q4
$3.63K Buy
+250
New +$3.04K ﹤0.01% 780

Other funds holding BMEA

Glen Eagle Advisors's BMEA Position: Q2 2026 in Review

Glen Eagle Advisors held its Biomea Fusion (BMEA) position steady in Q2 2026 at 250 shares worth $368. The position accounts for ﹤0.01% of the portfolio, ranked #1045.

Glen Eagle Advisors first reported a position in BMEA in Q4 2023 and has held it in 11 quarters since. The position peaked at $3.74K in Q1 2024. 61 funds tracked by Wall St. Rank hold BMEA as of Q2 2026.

  • Glen Eagle Advisors held 250 shares of Biomea Fusion worth $368 as of Q2 2026.
  • Glen Eagle Advisors left its Biomea Fusion share count unchanged in Q2 2026.
  • Biomea Fusion made up ﹤0.01% of Glen Eagle Advisors's portfolio in Q2 2026, its #1045 holding.
  • Glen Eagle Advisors first reported a position in Biomea Fusion in Q4 2023 and has held it in 11 quarters since.
  • Glen Eagle Advisors's Biomea Fusion position peaked at $3.74K in Q1 2024.
  • 61 funds tracked by Wall St. Rank held Biomea Fusion as of Q2 2026.

Based on Glen Eagle Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.